BCL2L1 and neoplasm: TCR-Tg SCID mice were protected against challenge with MOPC315-FLIP-L (Figure 1G), whereas injection of MOPC315-BclXL cells lead to tumor development with no delay compared to SCID controls (Figure 1H).